A detailed history of M&G PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, M&G PLC holds 198,968 shares of EXAS stock, worth $13.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
198,968
Previous 192,574 3.32%
Holding current value
$13.3 Million
Previous $10.2 Million 6.37%
% of portfolio
0.06%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$40.91 - $56.0 $261,578 - $358,064
6,394 Added 3.32%
198,968 $10.9 Million
Q2 2025

Aug 08, 2025

BUY
$40.31 - $58.08 $7.76 Million - $11.2 Million
192,574 New
192,574 $10.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.